About me
Christine Roth is the head of Global Product Strategy and Commercialization at Bayer Pharmaceuticals. In her three decades of industry experience at BMS, GSK, Novartis, and Bayer, she has played key roles in the development and launches of the first immuno-oncology therapy, the first intentionally designed targeted therapy combination, and multiple new drug classes across a wide range of therapeutic areas.
Christine is a member of the Pharmaceuticals Executive Committee of Bayer AG and serves of the Board of Vividion Therapeutics and Faron Pharmaceuticals.